质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALISERPATINIB
Rx
肿瘤学 & 血液学

ALISERPATINIB

赛普替尼 (Selpercatinib)
Generic (INN)
赛普替尼 (Selpercatinib)
Strength
40 mg
Packaging
120粒/瓶。
Indication
本品是一种激酶抑制剂，适用于：治疗具有转染重排 (RET) 基因融合的局部晚期或转移性非小细胞肺癌 (NSCLC) 成人患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
OSIMITIB
OSIMITIB
奥希替尼 (Osimertinib)
ALILSAZOMI
ALILSAZOMI
枸橼酸伊沙佐米 (Ixazomib citrate)
ALIMOBOTINIB
莫博赛替尼 (Mobocertinib)
ALIFUBATINIB
ALIFUBATINIB
富替巴替尼 (Futibatinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文